Vect-Horus has entered a research collaboration and exclusive licence option [...]
Lonza has acquired the rights to Nona Biosciences’ transferrin receptor [...]
Estonian biotechnology company Icosagen has completed a €45 million expansion [...]
BioInnovation Institute has opened its first international base in London [...]
Verdiva Bio has reported new preclinical data for two obesity [...]
The Society for RNA Therapeutics (SRT) has expanded its leadership [...]
London-based technology company Apoha has emerged from stealth with $36 [...]
Intellia Therapeutics has reported positive Phase 3 results for lonvoguran [...]
Regeneron Pharmaceuticals has entered the radiopharmaceuticals field through a multi-programme [...]
Aspargo Labs, Inc., a pharmaceutical company commercializing a highly absorbent [...]